Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study.
De Bus L, Depuydt P, Steen J, Dhaese S, De Smet K, Tabah A, Akova M, Cotta MO, De Pascale G, Dimopoulos G, Fujitani S, Garnacho-Montero J, Leone M, Lipman J, Ostermann M, Paiva JA, Schouten J, Sjövall F, Timsit JF, Roberts JA, Zahar JR, Zand F, Zirpe K, De Waele JJ; DIANA study group. De Bus L, et al. Among authors: akova m. Intensive Care Med. 2020 Jul;46(7):1404-1417. doi: 10.1007/s00134-020-06111-5. Epub 2020 Jun 9. Intensive Care Med. 2020. PMID: 32519003 Free PMC article.
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Korten V, Söyletir G, Yalçın AN, Oğünç D, Dokuzoğuz B, Esener H, Ulusoy S, Tünger A, Aygen B, Sümerkan B, Arman D, Dizbay M, Akova M, Hasçelik G, Eraksoy H, Başaran S, Köksal I, Bayramoğlu G, Akalın H, Sınırtaş M. Korten V, et al. Among authors: akova m. Mikrobiyol Bul. 2011 Apr;45(2):197-209. Mikrobiyol Bul. 2011. PMID: 21644063 Turkish.
Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria.
Petrosillo N, Giannella M, Antonelli M, Antonini M, Barsic B, Belancic L, Inkaya A C, De Pascale G, Grilli E, Tumbarello M, Akova M. Petrosillo N, et al. Among authors: akova m. Antimicrob Agents Chemother. 2014;58(2):851-8. doi: 10.1128/AAC.00871-13. Epub 2013 Nov 25. Antimicrob Agents Chemother. 2014. PMID: 24277037 Free PMC article.
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J; DALI Study. Roberts JA, et al. Among authors: akova m. Clin Infect Dis. 2014 Apr;58(8):1072-83. doi: 10.1093/cid/ciu027. Epub 2014 Jan 14. Clin Infect Dis. 2014. PMID: 24429437
Reply to Rhodes et al.
Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J. Roberts JA, et al. Among authors: akova m. Clin Infect Dis. 2014 Sep 15;59(6):907-8. doi: 10.1093/cid/ciu403. Epub 2014 May 27. Clin Infect Dis. 2014. PMID: 24867785 No abstract available.
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.
Blot S, Koulenti D, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, Roberts JA. Blot S, et al. Among authors: akova m. Crit Care. 2014 May 15;18(3):R99. doi: 10.1186/cc13874. Crit Care. 2014. PMID: 24887569 Free PMC article.
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.
Sinnollareddy MG, Roberts JA, Lipman J, Akova M, Bassetti M, De Waele JJ, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Dimopoulos G; DALI Study authors. Sinnollareddy MG, et al. Among authors: akova m. Crit Care. 2015 Feb 4;19(1):33. doi: 10.1186/s13054-015-0758-3. Crit Care. 2015. PMID: 25888060 Free PMC article.
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort.
Abdul-Aziz MH, Lipman J, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Dulhunty J, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Roberts JA; DALI Study Group. Abdul-Aziz MH, et al. Among authors: akova m. J Antimicrob Chemother. 2016 Jan;71(1):196-207. doi: 10.1093/jac/dkv288. Epub 2015 Oct 3. J Antimicrob Chemother. 2016. PMID: 26433783
Task force on management and prevention of Acinetobacter baumannii infections in the ICU.
Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, Petrosillo N, Seifert H, Timsit JF, Vila J, Zahar JR, Bassetti M; European Society of Intensive Care Medicine. Garnacho-Montero J, et al. Among authors: akova m. Intensive Care Med. 2015 Dec;41(12):2057-75. doi: 10.1007/s00134-015-4079-4. Epub 2015 Oct 5. Intensive Care Med. 2015. PMID: 26438224
238 results